Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Intrarenal hemodynamics in primary aldosteronism before and after treatment.

Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C.

J Clin Endocrinol Metab. 2009 Apr;94(4):1191-7. doi: 10.1210/jc.2008-2245. Epub 2009 Jan 13.

2.

Long-term renal outcomes in patients with primary aldosteronism.

Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C.

JAMA. 2006 Jun 14;295(22):2638-45. Erratum in: JAMA. 2006 Oct 18;296(15):1842.

PMID:
16772627
3.

Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment.

Wu VC, Kuo CC, Wang SM, Liu KL, Huang KH, Lin YH, Chu TS, Chang HW, Lin CY, Tsai CT, Lin LY, Chueh SC, Kao TW, Chen YM, Chiang WC, Tsai TJ, Ho YL, Lin SL, Wang WJ, Wu KD; TAIPAI Study Group.

J Hypertens. 2011 Sep;29(9):1778-86. doi: 10.1097/HJH.0b013e3283495cbb.

PMID:
21738054
4.

Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.

Fourkiotis V, Vonend O, Diederich S, Fischer E, Lang K, Endres S, Beuschlein F, Willenberg HS, Rump LC, Allolio B, Reincke M, Quinkler M; Mephisto Study Group.

Eur J Endocrinol. 2012 Dec 10;168(1):75-81. doi: 10.1530/EJE-12-0631. Print 2013 Jan.

5.

Relative glomerular hyperfiltration in primary aldosteronism.

Ribstein J, Du Cailar G, Fesler P, Mimran A.

J Am Soc Nephrol. 2005 May;16(5):1320-5. Epub 2005 Mar 30.

6.

Renal Resistive Index Predicts Postoperative Blood Pressure Outcome in Primary Aldosteronism.

Iwakura Y, Ito S, Morimoto R, Kudo M, Ono Y, Nezu M, Takase K, Seiji K, Ishidoya S, Arai Y, Funamizu Y, Miki T, Nakamura Y, Sasano H, Satoh F.

Hypertension. 2016 Mar;67(3):654-60. doi: 10.1161/HYPERTENSIONAHA.115.05924. Epub 2016 Jan 25.

7.

Relationships of plasma renin levels with renal function in patients with primary aldosteronism.

Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA.

Clin J Am Soc Nephrol. 2007 Jul;2(4):722-31. Epub 2007 Apr 25.

8.

Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.

Utsumi T, Kawamura K, Imamoto T, Nagano H, Tanaka T, Kamiya N, Nihei N, Naya Y, Suzuki H, Ichikawa T.

Int J Urol. 2013 Jul;20(7):685-91. doi: 10.1111/iju.12029. Epub 2012 Nov 27.

9.

Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.

Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA.

Hypertension. 2007 Nov;50(5):911-8. Epub 2007 Sep 24.

10.

Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.

Iwakura Y, Morimoto R, Kudo M, Ono Y, Takase K, Seiji K, Arai Y, Nakamura Y, Sasano H, Ito S, Satoh F.

J Clin Endocrinol Metab. 2014 May;99(5):1593-8. doi: 10.1210/jc.2013-2180. Epub 2013 Nov 27.

PMID:
24285678
11.

Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.

Novello M, Catena C, Nadalini E, Colussi GL, Baroselli S, Chiuch A, Lapenna R, Bazzocchi M, Sechi LA.

J Hypertens. 2007 Jul;25(7):1443-50.

PMID:
17563567
12.

Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.

Catena C, Colussi GL, Marzano L, Sechi LA.

Horm Metab Res. 2012 Mar;44(3):188-93. doi: 10.1055/s-0032-1301902. Epub 2012 Feb 20.

PMID:
22351477
13.

High sodium sensitivity and glomerular hypertension/hyperfiltration in primary aldosteronism.

Kimura G, Uzu T, Nakamura S, Inenaga T, Fujii T.

J Hypertens. 1996 Dec;14(12):1463-8.

PMID:
8986931
14.

Insulin sensitivity in patients with primary aldosteronism: a follow-up study.

Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, Novello M, Favret G, Melis A, Cavarape A, Sechi LA.

J Clin Endocrinol Metab. 2006 Sep;91(9):3457-63. Epub 2006 Jul 5.

PMID:
16822818
15.

Cardiovascular outcomes in patients with primary aldosteronism after treatment.

Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA.

Arch Intern Med. 2008 Jan 14;168(1):80-5. doi: 10.1001/archinternmed.2007.33.

PMID:
18195199
16.

Kidney impairment in primary aldosteronism.

Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, Chu TS, Huang KH, Wang SM, Lin YH, Chiang CK, Chang HW, Lin CY, Lin LY, Chiu JS, Hu FC, Chueh SC, Ho YL, Liu KL, Lin SL, Yen RF, Wu KD; TAIPAI Study Group.

Clin Chim Acta. 2011 Jul 15;412(15-16):1319-25. doi: 10.1016/j.cca.2011.02.018. Epub 2011 Feb 21.

PMID:
21345337
17.

Factors influencing outcome of surgery for primary aldosteronism.

Celen O, O'Brien MJ, Melby JC, Beazley RM.

Arch Surg. 1996 Jun;131(6):646-50.

PMID:
8645073
18.

Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.

Holaj R, Rosa J, Zelinka T, Štrauch B, Petrák O, Indra T, Šomlóová Z, Michalský D, Novák K, Wichterle D, Widimský J Jr.

J Hypertens. 2015 Apr;33(4):874-82; discussion 882. doi: 10.1097/HJH.0000000000000464.

19.

Adrenalectomy improves arterial stiffness in primary aldosteronism.

Strauch B, Petrák O, Zelinka T, Wichterle D, Holaj R, Kasalický M, Safarík L, Rosa J, Widimský J Jr.

Am J Hypertens. 2008 Oct;21(10):1086-92. doi: 10.1038/ajh.2008.243. Epub 2008 Jul 24.

PMID:
18654122
20.

Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.

Indra T, Holaj R, Štrauch B, Rosa J, Petrák O, Šomlóová Z, Widimský J Jr.

J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):1109-17. doi: 10.1177/1470320314549220. Epub 2014 Sep 30.

PMID:
25271250

Supplemental Content

Support Center